in this issue
Concordia res parvae crescent
Origins of socio-economic inequalities in cancer survival: a review
Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase
Allelic loss analysis of early-stage flat-type colorectal tumors
A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
Diverging trends in breast cancer mortality within Switzerland
Influence of thyroid hormone receptors on breast cancer cell proliferation
Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials
Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients
Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results
Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)
Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University
A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed–Sternberg (HRS) cells: high expression of interleukin-11 receptor α
Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma
Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity
Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy
Selecting predictors of cancer patients' overall perceptions of the quality of care received
Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study
Life expectancy as an indicator of outcome in follow-up of population-based cancer registries: the example of childhood leukemia
Troponins in prediction of cardiotoxic effects
Troponins in prediction of cardiotoxic effects
High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens
Warfarin–5-FU interactions
The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP
Quality of care in clinical oncology: from the dreamworld to the real world of outcome assessment
Pregnancy on imatinib: fatal outcome with meningocele